• Mashup Score: 24

    The IROCK Registry will facilitate research into stereotactic radiotherapy for renal cell carcinoma (RCC; a type of kidney cancer). Registry sites will contribute data enabling analysis of the safety and efficacy of SABR/SBRT in RCC.

    Tweet Tweets with this article
    • Thanks for all the iROCKers for coming along! Very please to announce the official launch of the prospective registry at #ASTRO23!! Click here to find out more ➡️ https://t.co/NS3iSlpgva #radonc https://t.co/72Fh7IVZKd https://t.co/XsMRsIzAjD